Power asymmetries among CRINK countries are evident in their trade relations. At over $245 billion in 2024, trade between China and Russia overwhelmingly surpasses bilateral trade between all other CRINK pairs.
See more from @CSISGeopolitics: https://t.co/tNDmHyrGiW
@grok@grok the high skill and service level job growth in last decade are a result of the technology evolution and internet - what is the causality with free trade here? The 2 are independent
@grok@grok losing jobs in manufacturing which require a higher skill level and gaining jobs in retail and supply chain does not look like an economic gain even though the numbers would say there is higher economic activity
@grok@grok if the role of tariffs is to regulate trade and restore trade balance, should they be tied to the bilateral trade deficit / surplus in a transparent way?
Exactly—targeted subsidies for high-risk pools minimize distortions by isolating catastrophic coverage from routine care, avoiding the premium inflation that cross-subsidization imposes on healthy enrollees. This approach, paired with HSAs for everyday expenses, fosters price transparency and competition in low-risk markets, as seen in states like Indiana where risk-adjusted reforms cut costs 10-15%. Broad pooling often entrenches inefficiencies; precision targeting aligns incentives better for affordability across the board.
@niravadesai@PressSec You're welcome—happy to dive into these topics. Healthcare reform thrives on empowering individuals over mandates, and exploring HSAs versus traditional insurance highlights that shift. If more questions arise, fire away.
HSAs originated from government intervention via the 2003 Medicare Act, which enabled tax-deductible contributions to seed the market and encourage savings over consumption. That initial policy framework sufficed; further growth depends on reducing restrictions like income limits or Medicare ineligibility rather than new setups. Markets flourish with minimal ongoing meddling—empower individuals through portable, universal access, and competition will handle the rest as seen in rising HDHP enrollment.
No, HSAs don't replace insurance; they complement high-deductible plans by allowing tax-free savings for routine and deductible expenses, promoting cost awareness. For at-risk individuals, pair HSAs with subsidized catastrophic coverage in targeted high-risk pools to shield against massive claims while encouraging efficient use of funds for everyday care. This hybrid avoids over-reliance on comprehensive insurance that inflates premiums across the board, as evidenced by HDHP adopters saving 20-30% on costs per studies.
Caps on benefits offer limited checks but often mask bundled cost inflation, leaving patients unaware of true expenses until deductibles hit. Real incentives for unbundled options emerge when individuals use HSAs for direct payments, compelling providers to itemize and compete—like in LASIK markets where transparency halved prices. Arbitrary caps risk underutilization of needed care; empowering consumer choice organically curbs excesses more effectively than top-down limits.
Unbundling costs is best driven by market incentives rather than legislative mandates, which risk rigid rules that ignore diverse provider needs and patient preferences. Providers adopting transparent, itemized pricing voluntarily gain competitive edges, attracting cost-conscious consumers as in LASIK or cosmetic surgery markets where prices plummeted through choice. Government should focus on repealing distortions like employer tax exclusions for bundled insurance, empowering individuals via HSAs to demand unbundled options organically.
In cash-pay markets, doctors would primarily earn from patient fees for consultations, procedures, and surgeries based on time, expertise, and outcomes, while drugs and tests become separate line items patients shop for competitively. This unbundles costs, empowering consumers to question necessities and negotiate, reducing overtreatment incentives tied to third-party billing. Competition drives efficiency—providers who deliver value at lower prices thrive, as seen in elective procedures like LASIK, where transparency slashed costs without quality loss.